variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
APOE-C130R,APOE,"This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).",High,Well-established,Pathogenic,0.14,Mental and behavioral;Nervous system,Complex/Other,Heterozygous,9343467;11950276;15123497;17428983,rs429358,4,chr19,45411941,C,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
GBA-L483P,GBA,"Causes Gaucher's disease, a recessive disorder whose symptoms include anemia, bruising, bone lesions, and spleen and liver issues. Reported to ClinVar by OMIM and Emory Genetics Laboratory (http://www.ncbi.nlm.nih.gov/clinvar/RCV000004509/), numerous publications cite this variant as causing the disease.",High,Likely,Pathogenic,,"Blood;Mouth, liver, and digestive;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
MEFV-E148Q,MEFV,"Some reports believe this cause Familial Mediterranean Fever in a recessive manner with reduced penetrance (i.e. not all get the disease). However, these reports lack strong statistical significance; other studies argue the variant is not associated with the disease.",Moderate,Uncertain,Pathogenic,0.012,Immune system,Recessive,Heterozygous,9668175;10090880;15458961;16439437;19820229,rs3743930,4,chr16,3304626,G,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
MBL2-G54D,MBL2,"This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele B. See R52C (variant D) and G57E (variant C).",Low,Likely,Pathogenic,0.1,Immune system,Recessive,Heterozygous,7564730;10199352;17872904,rs1800450,3,chr10,54531235,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Homozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
HFE-H63D,HFE,"There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.",Low,Uncertain,Pathogenic,0.11,Blood,Recessive,Heterozygous,8696333;9462220;12429850;14673107;17042772,rs1799945,1,chr6,26091179,G,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Heterozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
OCA2-H615R,OCA2,Associated with lighter skin pigmentation in East Asian populations.,Low,Likely,Benign,0.00065,Skin,Complex/Other,Heterozygous,17570052;20221248,rs1800414,,chr15,28197037,C,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
GAA-E689K,GAA,This is also known as the GAA*4 allozyme is frequent in the Asian population and appears to have somewhat reduced enzyme activity. Kroos et al. rule out pathogenic effect.,Low,Uncertain,Benign,0.03,Other,Complex/Other,Heterozygous,18301443,rs1800309,,chr17,78087041,A,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Heterozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
ABCC11-G180R,ABCC11,This variant is associated with dry type ear wax (a benign trait) in a recessive manner.,Low,Uncertain,Benign,0.098,Other,Unknown,Homozygous,14471313;16444273,rs17822931,,chr16,48258198,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
XPC-L16V,XPC,Reported as a nonpathogenic polymorphism.,Low,Uncertain,Benign,0.0047,Other,Unknown,Heterozygous,18544627,rs1870134,,chr3,14220023,C,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Heterozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
GJB2-V27I,GJB2,"Probable non-pathogenic; other variants in gene associated with hearing loss.
A few controversial mutations of uncertain or evolving clinical signiÔ¨Åcance are included in this prototype.
Examples include V27I, M34T, V37I, and E114G in the GJB2 gene and IVS2-2AG in the SLC26A5 gene.
This variant is also observed both in Case and Control in the study of hearing loss.",Low,Uncertain,Benign,0.0027,Hearing and vision,Unknown,Homozygous,11494963;15790391;19719946,rs2274084,,chr13,20763642,T,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=803343f5269c44b982b87582bdc31e462e11b1b9
